Drugs / enmetazobactam
last change Mar 2026 re-read 9 days ago

enmetazobactam

Small molecule

Developed for
urinary tract infection
Investigated by
Allecra · Medpace, Inc. · Linical Co., Ltd.

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved EU (EMA) Exblifep — 2024-03-21 europa.eu ↗
Approved US (FDA) EXBLIFEP — 2024-02-22 fda.gov ↗

Trials 7

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 14 trials
Phase 1 NCT03775668 Nov → Dec 2018 — Allecra Completed No outcome recorded
Phase 1 NCT03680352 Sep 2017 → Dec 2018 — Allecra Completed No outcome recorded
Phase 1 NCT03680378 Jul 2017 → Apr 2019 — Allecra Completed No outcome recorded
Phase 1 NCT03685084 Oct 2013 → Jan 2014 — Allecra Completed No outcome recorded
Phase 22 trials
Phase 2 NCT05826990 Sep 2023 → Sep 2025 urinary tract infection Allecra Unknown No outcome recorded
Phase 2 NCT03680612 Sep 2017 → Feb 2018 urinary tract infection Allecra Completed No outcome recorded
Phase 31 trial · 1 met primary
Phase 3 NCT03687255 Sep 2018 → Jan 2020 urinary tract infection Allecra Completed Met primary

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 8 sources stand behind the page.

FieldValueCited text
Known as enmetazobactam ClinicalTrials.gov intervention name — accepted as the source's own label NCT05826990 ↗
Known as AAI101 “Combination of cefepime 2 gram with AAI101 1 gram” NCT03680378 ↗
5

NCT03775668 ↗

NCT03680352 ↗

NCT03680612 ↗

NCT03685084 ↗

NCT03687255 ↗

Known as Enmetazobactam component of exblifep ChEMBL registry synonym — accepted as the source's own label CHEMBL4458276 ↗
Known as OCID-5090 ChEMBL registry synonym — accepted as the source's own label CHEMBL4458276 ↗
Modality Small molecule — CHEMBL4458276 ↗
Route Intravenous “cefepime 2 grams in combination with AAI101 1 gram intravenous infusion” NCT03680378 ↗